Basis: FMP quote price / unrounded FMP forward EPS in the trading currency, available after its recorded retrieval time. Source: stored company filings and market data; unavailable inputs remain N/A.
The forward PE ratio is N/A as of 2026-10-06T15:03:10.156Z.
Consensus retrieved: 2026-10-06T12:46:08.117Z. This records retrieval, including cache reads, rather than vendor publication. The calculation uses the separately dated price and estimate available at its as-of time.
Calculation as of: 2026-10-06T15:03:10.156Z.
Quote observation: 2026-10-06T15:00:30.000Z. Amounts in USD. The price header may show a later quote.
FMP input reference: 2d0a5a873814bcf3bdb8f0629e8f85f3c34e344d7cd5b6e560bd2cf85b63415c
Forward PE Ratio (N/A) = Dated Quote Price ($1.58) / Consensus Forward EPS ($-5.18)
FORWARD PE RATIO
N/A
Intelligent Bio Solutions Inc.
Market Cap
$5.26M
Forward PE Ratio
N/A
| NAME | MARKET CAP | FORWARD PE RATIO |
|---|---|---|
| Intelligent Bio Solutions Inc. (INBS) | $5.26M | N/A |
| Liminatus Pharma, Inc. Class A Common Stock (LIMN)vs › | $5.21M | N/A |
| Lunai Bioworks Inc. (LNAI)vs › | $5.19M | N/A |
| Alzamend Neuro Inc (ALZN)vs › | $5.36M | N/A |
| Gelteq Limited Ordinary Shares (GELS)vs › | $5.17M | N/A |
| Imunon, Inc. (IMNN)vs › | $5.04M | N/A |
| Basel Medical Group Ltd Ordinary Shares (BMGL)vs › | $5.01M | N/A |
| Acurx Pharmaceuticals, Inc. (ACXP)vs › | $5.54M | N/A |
| enVVeno Medical Corporation (NVNO)vs › | $5.70M | N/A |
| Bio Green Med Solution, Inc. (BGMS)vs › | $4.83M | N/A |
Trailing P/E
N/A
reported TTM EPS
Forward P/E
N/A
consensus EPS · fiscal year ending 2027-06-30
At the dated quote price of $1.58, each upcoming fiscal year's consensus EPS implies a different multiple — how quickly the price is "paid down" by expected earnings if the estimates hold.
| Fiscal year end | Consensus EPS | Estimate range | Analysts | Implied P/E |
|---|---|---|---|---|
| 2027-06-30 | $-5.18 | $-5.18 – $-5.18 | 1 | n/m |
| 2028-06-30 | $-4.06 | $-4.06 – $-4.06 | 1 | n/m |
| 2029-06-30 | $-2.87 | $-2.87 – $-2.87 | 1 | n/m |
Source: FMP analyst consensus estimates, refreshed with the daily precompute. "n/m" = the consensus EPS is not positive, so a multiple is undefined. There is no forward P/E history chart here because charting one would require the estimates as they stood in the past, which we do not store — see the trailing P/E history for how the realized multiple has moved.
PE Ratio = Share Price / Diluted EPS (TTM)
The price-to-earnings ratio measures how much investors pay for each dollar of trailing earnings. A lower PE can indicate a cheaper valuation; a higher PE implies higher growth expectations.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
